Sales deregulation shakes up Japan's OTC sector
This article was originally published in Scrip
Supermarkets and convenience stores in Japan have begun selling a wide range of over-the-counter medicines under a June 1st revision to the Pharmaceutical Affairs Law.
You may also be interested in...
While disappointing result will probably put an end to single-drug plans in ovarian cancer, the blockbuster anti-PD-1 immunotherapy remains in combination development for the indication.
Japanese firm in discussions with regulator as high-need novel therapy for spinocerebellar degeneration misses endpoint but shows promise in pooled analysis.